Publications
Original Article
Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunity
Cancer Vaccines
2008
Authors:
Goodell V, Waisman J, Salazar LG, dela Rosa C, Link J, Coveler AL, Webster W, Childs JS, Fintak PA, Higgins DM and Disis ML
Journal:
Molecular Cancer Therapeutics
Volume:
7(3)
Page:
449-54
Original Article
An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer
Cancer Vaccines
2008
Authors:
Kalli KR, Krco CJ, Hartmann LC, Goodman K, Maurer MJ, Yu C, Johnson EM, Erskine CL, Disis ML, Wettstein PJ, Fikes JD, Beebe M, Ishioka G, Knutson KL
Journal:
Cancer Research
Volume:
68(12)
Page:
4893-901
Original Article
Functional T cell responses to tumor antigens in breast cancer patients have a distinct phenotype and cytokine signature
T Cell Function & Therapy
2007
Authors:
Inokuma M, delaRosa C, Schmitt C, Haaland P, Siebert J, Petry D, Tang MX, Suni MA, Ghanekar SA, Gladding D, Dunne JF, Maino VC, Disis ML and Maecker HT
Journal:
The Journal of Immunology
Volume:
179(4)
Page:
2627-33
Methods
Sensitivity and specificity of tritiated thymidine incorporation and ELISPOT assays in identifying antigen specific T cell immune responses
Measuring Human Immunity
2007
Authors:
Goodell V, dela Rosa C, Slota M, MacLeod B and Disis ML
Journal:
BMC Immunology
Volume:
8
Page:
21
Original Article
Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming
T Cell Function & Therapy
2007
Authors:
Dang Y, Knutson KL, Goodell V, dela Rosa C, Salazar LG, Higgins D, Childs J, Disis ML
Journal:
Clinical Cancer Research
Volume:
13(6)
Page:
1883-91
Review Article
CD4 regulatory T cells in human cancer pathogenesis
General Immune Research
2007
Authors:
Knutson KL, Disis ML, Salazar LG.
Journal:
Cancer Immunology Immunotherapy
Volume:
56(3)
Page:
271-85
Original Article
Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response
T Cell Function & Therapy
2007
Authors:
Wang LX, Shu S, Disis ML and Plautz GE
Journal:
Blood
Volume:
109(11)
Page:
4865-76
Original Article
Kinetics of tumor-specific T-cell response development after active immunization in patients with HER-2/neu overexpressing cancers
Cancer Vaccines
2007
Authors:
Salazar LG, Coveler AL, Swensen RE, Gooley TA, Goodell V, Schiffman K and Disis ML
Journal:
Clinical Immunology
Volume:
125(3)
Page:
275-80
Review Article
Targeting serum antibody for cancer diagnosis: a focus on colorectal cancer
Cancer Diagnostics
2007
Authors:
Lu H, Goodell V, Disis ML.
Journal:
Expert Opinion on Therapeutic Targets
Volume:
11(2)
Page:
235-44
Original Article
Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors
Measuring Human Immunity
2007
Authors:
Ghanekar SA, Bhatia S, Ruitenberg JJ, delaRosa C, Disis ML, Maino VC, Maeker HT and Waters CA
Journal:
Journal of Immune Based Therapies and Vaccines
Volume:
5
Page:
7